Asian scientists unveil 10-year roadmap to build synthetic cells

Scientists from six Asian countries have launched an ambitious 10-year effort to build synthetic cells from non-living molecules, marking the region's first coordinated push to create artificial single-celled life.

The roadmap, published on May 26 in the journal Nature Biotechnology, was developed through the SynCell Asia Initiative with more than 100 scientists from China, Japan, South Korea, Singapore, Thailand and Malaysia.

Building a single-celled organism from scratch using phospholipids, proteins, DNA and other biological macromolecules is one of the most challenging scientific goals in life science. Achieving this would not only deepen our understanding of "what is life" but also enable programmable, customizable functional cells for biomanufacturing and biomedicine, driving systemic change across fundamental science and biotechnology.

Over the past several decades, global efforts have taken shape in Europe and the United States. However, while individual functional modules have advanced considerably, the systemic integration of these modules into a fully functional synthetic cell in space and time remains an unmet global challenge.

In 2023, scientists from six Asian countries formally established the SynCell Asia Initiative. This marked a powerful, distinctive voice for Asia in the global synthetic cell landscape. Through repeated SynCell Asia Workshops, members engaged in deep discussions, aligned visions, and gradually developed a scientific framework and action agenda rooted in Asian perspectives and regional strengths. The roadmap is the culmination of those efforts.

The roadmap identifies four core challenges in building a synthetic cell: metabolic continuity, ribosome autonomy, modular design rules and spatiotemporal coordination. To address these challenges, the roadmap advocates a "central factory plus distributed workstations" model: standardized synthetic cell chassis and reagents are prepared centrally and distributed to participating labs, forming a closed-loop Design-Build-Test-Learn (DBTL) cycle. Single-syncell omics using automated platforms to collect genome, transcriptome, proteome, metabolome, and quantitative imaging data at single-cell resolution will provide high-dimensional data for machine learning models. Researchers also proposed combining "white-box" mechanistic models with "black-box" data-driven models to better predict and control synthetic cell behavior.

The roadmap has a two-stage, 10-year target:

Phase 1: ProtoCell (Years 1-5)

A stable phospholipid vesicle with a minimal genome (≥200 genes), ≥90% of proteins expressed by a cell-free transcription-translation system, and endogenous synthesis of key metabolites. A "digital twin" of the synthetic cell will also be developed to explore how mechanical and biochemical signals coordinate division.

Phase 2: AutoCell (Years 6-10)

Achieve endogenous, genome-encoded ribosome regeneration, replacing the external cell-free expression system and enabling true self-replication. The AutoCell must complete ≥10 continuous, coordinated growth-division cycles, evolve under environmental selection pressures, and form synthetic cell communities with emergent behaviors such as material exchange and division of labor.

The SynCell Asia roadmap leverages deep technological complementarities across Asian countries, creating a novel model of cross-border collaboration, shared infrastructure, and open standards. The paradigm will transform synthetic cell research from fragmented, modular exploration into systematic, standardized, collaborative construction.